JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
24h
Current
Min
4.02
Max
4.22
Recommendations | Buy |
|---|---|
12 Months Forecast | +170.27% upside |
Next Earnings | 31 Oct 2025 |
|---|
By Acuity
81%
19%
344 / 371 Healthcare
Past performance is not a reliable indicator of future results.
24 Oct 2025, 13:04 UTC
Eli Lilly Agrees to Acquire Adverum Biotechnologies
DJ
Read
24 Oct 2025, 12:34 UTC
Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY
DJ
Read
24 Oct 2025, 12:34 UTC
Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY
DJ
Read
24 Oct 2025, 12:33 UTC
Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY
DJ
Read
24 Oct 2025, 12:30 UTC
Lilly To Acquire Adverum Biotechnologies >LLY ADVM
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 11 USD 170.27%
High 30 USD
Low 3 USD
Based on 6 Wall Street analysts offering 12 month price targets forAdverum Biotechnologies Inc - Dist in the last 3 months.
By TipRanks
Buy
6 ratings
3
Buy
3
Hold
0
Sell
Based on 6 analysts giving stock ratings to Adverum Biotechnologies Inc - Dist in the past 3 months.
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
$